Temozolamide Suspension

Temozolomide Suspension integrates a potent DNA-alkylating agent within a stabilized liquid vehicle to optimize drug solubility and ensure consistent cytotoxic activity against high-grade gliomas. This formulation addresses critical clinical barriers by providing a precise, weight-based dosing alternative for patients with dysphagia or those requiring titrations that traditional capsules cannot accommodate. By facilitating easier administration and reliable gastrointestinal absorption, this delivery system enhances therapeutic adherence and ensures optimal systemic exposure for improved patient outcomes in neuro-oncology.